Search - tctmd.com

Displaying 181 - 200 of 379

Sort: Relevancy | Date

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

Caitlin E. Cox

August 31, 2021

News Conference News ESC 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

Todd Neale

August 30, 2021

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Michael O'Riordan

July 27, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Highest-Risk Patients Gain the Most From Intensive BP Therapy

Todd Neale

April 20, 2021

News Daily News

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

L.A. McKeown

April 07, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Caitlin E. Cox

March 24, 2021

Advertisement

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Making the Case for Sex-Specific CVD Guidelines

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

June 2021 News Roundup

Prediabetes Linked to Higher MACE Risk

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Highest-Risk Patients Gain the Most From Intensive BP Therapy

Mobile Tech May Boost CAD Secondary Prevention for Older Adults

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content